Break it Down: EBR lands vital FDA approval

EBR Systems lands FDA approval for Wise CRT system, a world first solution proving pacing options for the left side of the heart.

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Tylah Tully reveals all on EBR Systems (ASX:EBR), who have won US FDA approval for its WISE CRT system, the world’s first and only wireless solution for pacing the left side of the heart.

Watch the video to learn more.

While EBR Systems is a Stockhead advertiser, it did not sponsor this content.

Originally published as Break it Down: EBR lands vital FDA approval